Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Fiamegos, Yiannis C ^a   Kastritis, Panagiotis L ^b   Exarchou, Vassiliki ^a   Han, Haley ^c   Bonvin, Alexandre M J J ^b   Vervoort, Jacques ^d   Lewis, Kim ^e   Hamblin, Michael R ^c,f,g   Tegos, George P ^c,f,h  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UTRECHT UNIVERSITY   (Netherlands)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e NORTHEASTERN UNIVERSITY   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^h UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3',5' DICAFFEOYLQUINIC ACID; 4',5' DICAFFEOYLQUINIC ACID; ARTEMISIA ABSINTHIUM EXTRACT; BERBERINE; CHLOROGENIC ACID; CIPROFLOXACIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; METICILLIN; MOXIFLOXACIN; NORFLOXACIN; PHENOL DERIVATIVE; TETRACYCLINE; UNCLASSIFIED DRUG; ABC TRANSPORTER; ANTIINFECTIVE AGENT; CAFFEOYLQUINIC ACID; DRUG DERIVATIVE; PLANT EXTRACT; QUINIC ACID;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTEMISIA ABSINTHIUM; ARTICLE; BACILLUS CEREUS; BIOFILM; CANDIDA ALBICANS; DRUG IDENTIFICATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GRAM POSITIVE BACTERIUM; HEMOLYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; SOLID PHASE EXTRACTION; STAPHYLOCOCCUS AUREUS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; PHYSIOLOGY; PROTEIN CONFORMATION;

ARTEMISIA ABSINTHIUM; POSIBACTERIA;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ARTEMISIA ABSINTHIUM; ATP-BINDING CASSETTE TRANSPORTERS; BERBERINE; BIOFILMS; DRUG RESISTANCE, MULTIPLE; DRUG SYNERGISM; GRAM-POSITIVE BACTERIA; HEMOLYSIS; HUMANS; MODELS, MOLECULAR; PLANT EXTRACTS; PROTEIN CONFORMATION; QUINIC ACID;

EID: 79953683464     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018127     Document Type: Article

References (65)

1. Paulsen IT, Chen J, Nelson KE, Saier MHJ, (2002) Comparative genomics of microbial drug efflux systems. In: Lewis K, editors. Microbial Multidrug Efflux Norfolk Horizon Press pp. 5-21.
2. Piddock L, (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19: 382-402.
3. Poole K, (2005) Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51.
4. Piddock LJV, (2006) Multidrug-resistance efflux pumps- Not just for resistance. Nat Rev Microbiol 4: 629-636.
5. Lomovskaya O, Watkins W, (2001) Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J Mol Microbiol Biotechnol 3: 225-236.
6. Lomovskaya O, Zgurskaya HI, Totrov M, Watkins WJ, (2007) Waltzing transporters and 'the dance macabre' between humans and bacteria. Nat Rev Drug Discov 6: 56-65.
7. Lewis K, Ausubel FM, (2006) Prospects for plant-derived antibacterials. Nat Biotechnol 24: 1504-1507.
8. Tegos G, (2006) Substrates and Inhibitors of microbial efflux pumps; Redefine the Role of Plant Antimicrobilas Naturally occurring bioactive compounds: a new and safe alternative for control of pests and microbial diseases; In: Rai M, Carpinella CM, editors. Cambridge Cambridge University Press.
9. Tegos G, Stermitz F, Lomovskaya O, Lewis K, (2002) Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob Agents Che 46: 3133-3141.
10. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K, (2000) Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci U S A 97: 1433-1437.
11. Belofsky G, Carreno R, Lewis K, Ball A, Casadei G, et al. (2006) Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus. J Nat Prod 69: 261-264.
12. Belofsky G, Percivil D, Lewis K, Tegos G, Ekart J, (2004) Phenolic Metabolites of Dalea versicolor that Enhance Antibiotic Activity Against Multi-Drug Resistant Bacteria. J Nat Prod 67: 481-484.
13. Morel C, Stermitz FR, Tegos G, Lewis K, (2003) Isoflavones as potentiators of antibacterial activity. J Agric Food Chem 51: 5677-5679.
14. Stavri M, Piddock LJV, Gibbons S, (2007) Bacterial efflux pump inhibitors from natural sources. J Antimicr Chemother 59: 1247-1260.
15. Stermitz F, Cashman KK, Halligan KM, Morel C, Tegos G, et al. (2003) Polyacylated neohesperidosides from Geranium caespitosum Bacterial multidrug resistance pump inhibitors. Bioorg Med Chem Lett 13: 1915-1918.
16. Stermitz F, Scriven L, Tegos G, Lewis K, (2002) Two novel flavones from Artemisia annua potentiate the action of berberine against Staphylococcus aureus. Planta Med 68: 1140-1141.
17. Juteau F, Jerkovic I, Masotti V, Milos M, Mastelic J, et al. (2003) Composition and Antimicrobial Activity of the Essential Oil of Artemisia absinthium from Croatia and France. Planta Med 69: 158-161.
18. Reinke R, King PJ, Victoria GJ, McDougall RB, Ma G, et al. (2002) Dicaffeoyltartaric Acid Analogues Inhibit Human Immunodeficiency Virus Type 1 (HIV-1) Integrase and HIV-1 Replication at Nontoxic Concentrations. J Med Chem 45: 3669-3683.
19. Hishamoto M, Kikuzaki H, Ohigashi HN, (2003) Antioxidant Compounds from the Leaves of Peucedanum japonicum Thunb. J Agric Food Chem 51: 5255-5261.
20. Azuma K, Nakayama M, Koshioka M, Ippoushi K, Yamaguchi Y, et al. (1999) Phenolic Antioxidants from the Leaves of Corchorus olitorius L. J Agric Food Chem 47: 3963-3966.
21. Ohnishi M, Morishita H, Iwahashi H, Toda S, Shirataki Y, et al. (1994) Inhibitory effects of chlorogenic acids on linoleic acid peroxidation and haemolysis. Phytochemistry 36: 579-583.
22. Tsuchiya T, Suzuki O, Igarashi K, (1996) Protective effects of chlorogenic acid on paraquat-induced oxidative stress in rats. Biosci Biotechnol Biochem 60: 765-768.
23. Exarchou V, Godejohann M, van Beek T, Gerothanassis I, Vervoort J, (2003) LC-UV-Solid-Phase Extraction-NMR-MS Combined with a Cryogenic Flow Probe and Its Application to the Identification of Compounds Present in Greek Oregano. Anal Chem 75: 6288-6294.
24. Clifford MN, Johnston KL, Knight S, Kuhnert N, (2003) Hierarchical Scheme for LC-MSn Identification of Chlorogenic Acids. J Agric Food Chem 51: 2900-2911.
25. Bandyopadhyay G, Biswas T, Roy KC, Mandal S, Mandal C, et al. (2004) Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells. Blood 104: 2514-2522.
26. Singh N, Rajini PS, (2008) Antioxidant-mediated protective effect of potato peel extract in erythrocytes against oxidative damage. Chem-Biol Interact 173: 97-104.
27. Kaatz GW, Seo SM, O'Brien L, Wahiduzzaman M, Foster TJ, (2000) Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Antimicrob Agents Chemother 44: 1404-1406.
28. Samosorn S, Bremner JB, Ball A, Lewis K, (2006) Synthesis of functionalised 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors. Bioorg Med Chem 14: 857-865.
29. Markham P, Westhaus E, Klyachko K, Johnson ME, Neyfakh AA, (1999) Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob Agents Chemother 43: 2404-2408.
30. Dawson R, Locher KP, (2006) Structure of a bacterial multidrug ABC transporter. Nature 443: 180-185.
31. Huang Y, Lemieux MJ, Song J, Auer M, Wang DN, (2003) Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301: 616-620.
32. de Vries S, van Dijk M, Bonvin AM, (2010) The HADDOCK web server for data-driven biomolecular docking. 5: 883-897 http://haddock.chem.uu.nl/services/HADDOCK. Nat Protoc.
33. Huang Y, Lemieux MJ, Song J, Auer M, Wang DN, (2003) Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301: 616-620.
34. Dawson RJP, Locher KP, (2006) Structure of a bacterial multidrug ABC transporter. Nature 443: 180-185.
35. Huang XY, Huang XJ, Cui HR, Zhang JH, Chen SM, (2003) Present status of antibiotic resistance of clinical isolates from 1998 to 2002 and the rational use of antibiotics. Chinese J Antibiot 28: 718-722.
36. Kastritis PL, Bonvin AM, (2010) Are scoring functions in protein-protein docking ready to predict interactomes? Clues from a novel binding affinity benchmark. J Proteom Res 9: 2216-2225.
37. Gibbons S, Moser E, Kaatz GW, (2004) Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus. Planta Med 70: 1240-1242.
38. Chérigo L, Pereda-Miranda R, Fragoso-Serrano M, Jacobo-Herrera N, Kaatz GW, et al. (2008) Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides. J Nat Prod 71: 1037-1045.
39. Pereda-Miranda R, Kaatz GW, Gibbons S, (2006) Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus. J Nat Prod 69: 406-409.
40. Michalet S, Cartier G, David B, Mariotte AM, Dijoux-franca MG, et al. (2007) N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors. Bioorg Med Chem Lett 17: 1755-1758.
41. Thota N, Koul S, Reddy MV, Sangwan PL, Khan IA, et al. (2008) Citral derived amides as potent bacterial NorA efflux pump inhibitors. Bioorg Med Chem 16: 6535-6543.
42. Falcão-Silva V, Silva DA, Souza Mde F, Siqueira-Junior JP, (2009) Modulation of drug resistance in Staphylococcus aureus by a kaempferol glycoside from Herissantia tiubae (Malvaceae). Phytother Res 10: 1367-1370.
43. Mohtar M, Johari SA, Li AR, Isa MM, Mustafa S, et al. (2009) Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA). Curr Microbiol 59: 181-186.
44. Lechner D, Gibbons S, Bucar F, (2007) Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. J Antimicrob Chemother 62: 345-348.
45. Wei P, Kaatz GW, Kerns RJ, (2004) Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps. Bioorg Med Chem Lett 14: 3093-3097.
46. Sangwan P, Koul JL, Koul S, Reddy MV, Thota N, et al. (2008) Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors. Bioorg Med Chem 16: 9847-9857.
47. German N, Wei P, Kaatz GW, Kerns RJ, (2008) Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps. Eur J Med Chem 43: 2453-2463.
48. Sabatini S, Kaatz GW, Rossolini GM, Brandini D, Fravolini A, (2008) From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. J Med Chem 51: 4321-4330.
49. Rodrigues L, Wagner D, Viveiros M, Sampaio D, Couto I, et al. (2008) Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. J Antimicrob Chemother 61: 1076-1082.
50. Truong-Bolduc QC, Zhang X, Hooper DC, (2003) Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus. J Bacteriol 165: 3127-3138.
51. Jonas BM, Murray BE, Weinstock GM, (2001) Characterization of emeA, a norA homolog and multidrug resistance efflux pump, in Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 45: 3574-3579.
52. Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, et al. (2006) Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS pathogens 2.
53. Schram K, Miketova P, Slanina J, Humpa O, Taborska E, (2004) Mass spectrometry of 1,3- and 1,5-dicaffeoylquinic acids. Journal of Mass Spectrometry 39: 384-395.
54. Clinical and Laboratory Standards Institute (2008) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard CLSI Document M27-A3. Wayne, Pa: CLSI.
55. Clinical and Laboratory Standards Institute (2008) Reference Method for Broth Dilution Antimicrobial Susceptibility Testing. Approved Standard CLSI Document M39-A3.29. Wayne, Pa: CLSI.
56. Eliopoulos GM, Moellering RC, (1991) Antibiotics in laboratory medicine. In: Lorian V, editors. Antibiotics in laboratory medicine Baltimore, MD Williams & Wilkins Co pp. 432-492.
57. Ciornei CD, Sigurdardóttir T, Schmidtchen A, Bodelsson M, (2005) Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37 Antimicrob Agents Chemother 49: 2845-2850.
58. Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, et al. (2007) Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 3: 18.
59. Ball AR, Casadei G, Samosorn S, Bremner JB, Ausubel FM, et al. (2006) Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial. ACS chemical biology 1: 594-600.
60. O'Toole GA, Kolter R, (1998) Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 28: 449-461.
61. Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, et al. (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323: 1718-1722.
62. Dominguez C, Boelens R, Bonvin AMJJ, (2003) HADDOCK: A protein-protein docking approach based on biochemical or biophysical information. Journal of the American Chemical Society 125: 1731-1737.
63. de Vries SJ, van Dijk M, Bonvin AM, (2010) The HADDOCK web server for data-driven biomolecular docking. Nature Protocols 5: 883-897.
64. Brunger AT, Adams PD, Clore GM, Delano WL, Gros P, et al. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D 54: 905-921.
65. Jorgensen WL, Tirado-Rives J, (1988) The OPLS potential functions for proteins. Energy minimizations for crystals of cyclic peptides and crambin. Journal of the American Chemical Society 110: 1657-1666.